54.86
price up icon1.29%   0.70
after-market Dopo l'orario di chiusura: 55.00 0.14 +0.26%
loading

Biomarin Pharmaceutical Inc Azioni (BMRN) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
10.77%
825.41
745.14 747.31 745.74 712.03
Cost Of Revenue
0.97%
150.09
151.56 136.14 188.46 130.46
Gross Profit
13.77%
675.32
593.59 611.17 557.28 581.57
Operating Expenses
7.77%
398.43
369.69 449.77 443.39 461.12
Benefits Costs and Expenses
4.04%
527.54
507.06 577.67 611.30 579.89
Costs And Expenses
5.23%
548.52
521.25 585.91 631.85 591.58
Operating Income/Loss
23.67%
276.89
223.89 161.41 113.89 120.45
Income/Loss From Continuing Operations Before Tax
25.11%
297.87
238.09 169.64 134.44 132.14
Income Tax Expense/Benefit, Deferred
17.28%
33.34
28.43 42.39 12.17 1.252
Income Tax Expense/Benefit
9.41%
57.34
52.40 44.70 28.36 24.96
Income/Loss From Continuing Operations After Tax
29.54%
240.53
185.69 124.94 106.08 107.17
Net Income/Loss
29.54%
240.53
185.69 124.94 106.08 107.17
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.49%
191.91
190.97 0.221 190.43 190.11
Diluted Average Shares
0.31%
197.09
196.47 0.025 197.15 200.50
Basic Earnings Per Share
28.87%
1.25
0.97 0.66 0.56 0.56
Diluted Earnings Per Share
29.47%
1.23
0.95 0.65 0.55 0.55
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$36.32
price up icon 2.95%
$86.70
price up icon 2.23%
$31.77
price up icon 3.59%
$102.21
price up icon 3.64%
$147.28
price up icon 2.27%
biotechnology ONC
$335.16
price down icon 1.63%
Capitalizzazione:     |  Volume (24 ore):